GoodRx (GDRX) Stock Tumbles Over 40% After Pulling Guidance, Analyst Blames Kroger (KR) For the Slump
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
GoodRx Holdings Inc. (GDRX) PT Lowered to $12 at Goldman Sachs
May 10, 2022 7:00 AM EDTGoldman Sachs analyst Eric Sheridan lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $12.00 (from $30.00) while maintaining a Buy rating.
The analyst commented, "In its Q1 22 earnings report, GoodRx presented a solid quarterly report but framed the forward business trajectory as impacted by a "grocer" partner that had... More
SVB Leerink Downgrades GoodRx Holdings Inc. (GDRX) to Market Perform
May 10, 2022 6:02 AM EDTSVB Leerink analyst Stephanie Davis downgraded GoodRx Holdings Inc. (NASDAQ: GDRX) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on GoodRx Holdings Inc. click here. For more ratings news on GoodRx Holdings Inc. click here.
Shares of GoodRx Holdings Inc. closed at $10.75 yesterday.
... MoreGoodRx Holdings Inc. (GDRX) PT Lowered to $15 at Barclays
May 10, 2022 5:43 AM EDTBarclays analyst Ross Sandler lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $15.00 (from $28.00) while maintaining a Overweight rating.... More
RBC Capital Downgrades GoodRx Holdings Inc. (GDRX) to Sector Perform
May 10, 2022 3:33 AM EDTRBC Capital analyst Mark Mahaney downgraded GoodRx Holdings Inc. (NASDAQ: GDRX) from Outperform to Sector Perform with a price target of $8.00 (from $35.00).
For an analyst ratings summary and ratings history on GoodRx Holdings Inc.... More
